Catalyst Funds Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$493K	Buy	+17,800	New	+$493K	0.14%	199
2024 Q4	–	Sell	-4,600	Closed	-$115K	–	817
2024 Q3	$115K	Buy	+4,600	New	+$115K	0.03%	459